Privium Fund Management B.V. Ultragenyx Pharmaceutical Inc. Transaction History

Privium Fund Management B.V.

$469 Million
Q2 2025

A detailed history of Privium Fund Management B.V. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 253,304 shares of RARE stock, worth $7.12 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares

253,304

Previous 249,804 1.4%

Holding current value

$7.12 Million

Previous $9.05 Million 1.82%

% of portfolio

1.96%

Previous 2.37%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$31.06 - $39.3 $108,710 - $137,550	3,500 Added 1.4%	253,304 $9.21 Million
Q1 2025 May 08, 2025	SELL	$36.21 - $45.78 $310,536 - $392,609	-8,576 Reduced 3.32%	249,804 $9.05 Million
Q4 2024 Feb 10, 2025	BUY	$42.07 - $57.72 $667,566 - $915,900	15,868 Added 6.54%	258,380 $10.9 Million
Q3 2024 Nov 01, 2024	SELL	$40.21 - $59.36 $365,508 - $539,582	-9,090 Reduced 3.61%	242,512 $13.5 Million
Q2 2024 Jul 31, 2024	BUY	$37.42 - $51.61 $1.37 Million - $1.88 Million	36,500 Added 16.97%	251,602 $10.3 Million
Q1 2024 Apr 30, 2024	BUY	$43.02 - $53.69 $2.09 Million - $2.61 Million	48,596 Added 29.19%	215,102 $10 Million
Q4 2023 Feb 13, 2024	BUY	$31.73 - $49.19 $1.63 Million - $2.52 Million	51,265 Added 44.49%	166,506 $7.96 Million
Q3 2023 Nov 06, 2023	BUY	$34.92 - $46.66 $104,760 - $139,980	3,000 Added 2.67%	115,241 $4.11 Million
Q2 2023 Jul 25, 2023	BUY	$37.35 - $52.15 $56,025 - $78,225	1,500 Added 1.35%	112,241 $5.18 Million
Q1 2023 May 03, 2023	BUY	$36.99 - $48.71 $147,960 - $194,840	4,000 Added 3.75%	110,741 $4.44 Million
Q4 2022 Feb 02, 2023	BUY	$33.72 - $46.33 $822,768 - $1.13 Million	24,400 Added 29.63%	106,741 $4.95 Million
Q3 2022 Nov 03, 2022	SELL	$39.96 - $66.14 $901,417 - $1.49 Million	-22,558 Reduced 21.5%	82,341 $3.34 Million
Q2 2022 Jul 28, 2022	SELL	$45.8 - $85.4 $358,522 - $668,511	-7,828 Reduced 6.94%	104,899 $6.26 Million
Q1 2022 May 10, 2022	BUY	$62.2 - $84.4 $677,731 - $919,622	10,896 Added 10.7%	112,727 $8.19 Million
Q4 2021 Feb 09, 2022	BUY	$73.71 - $87.86 $7.51 Million - $8.95 Million	101,831 New	101,831 $8.58 Million

Others Institutions Holding RARE

# of Institutions

335

Shares Held

89.6M

Call Options Held

1.05M

Put Options Held

1.01M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $1.97B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management B.V. with notifications on news.

Account

Privium Fund Management B.V. Ultragenyx Pharmaceutical Inc. Transaction History